Dmitrii Kriukov

Dmitrii Kriukov

Auto-generated profile, based on publicly available information

Dmitrii Kriukov

Artificial Intelligence Research Institute, Moscow, Russian Federation and Skolkovo Institute of Science and Technology, Moscow, Russian Federation

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2024 in Aging Cell
Verified
Journal Article
Open access
DKDmitrii Kriukov
Dmitrii Kriukov
EKEkaterina Kuzmina
Ekaterina Kuzmina
EEEvgeniy Efimov
Evgeniy Efimov
DDDmitry V. Dylov
Dmitry V. Dylov
EKEkaterina E. Khrameeva
Ekaterina E. Khrameeva
Epigenetic aging clocks have been widely used to validate rejuvenation effects during cellular reprogramming. However, these predictions are unverifiable because the true biological age of reprogrammed cells remains unknown. We present an analytical framework to consider rejuvenation predictions from the uncertainty perspective. Our analysis reveals that the DNA methylation profiles across reprogramming are poorly represented in the aging data used to train clock models, thus introducing high epistemic uncertainty in age estimations. Moreover, predictions of different published clocks are inconsistent, with some even suggesting zero or negative rejuvenation. While not questioning the possibility of age reversal, we show that the high clock uncertainty challenges the reliability of rejuvenation effects observed during in vitro reprogramming before pluripotency and throughout embryogenesis. Conversely, our method reveals a significant age increase after in vivo reprogramming. We recommend including uncertainty estimation in future aging clock models to avoid the risk of misinterpreting the results of biological age prediction.

14 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDmitrii Kriukov
Dmitrii Kriukov
EKEkaterina Khrameeva
Ekaterina Khrameeva
VGVadim N Gladyshev
Vadim N Gladyshev
SDSergey Dmitriev
Sergey Dmitriev
ATAlexander Tyshkovskiy
Alexander Tyshkovskiy
Partial somatic cell reprogramming has been touted as a promising rejuvenation strategy. However, its association with mechanisms of aging and longevity at the molecular level remains unclear. We identified a robust transcriptomic signature of reprogramming in mouse and human cells that revealed co-regulation of genes associated with reprogramming and response to lifespan-extending interventions, including those related to DNA repair and inflammation. We found that age-related gene expression changes were reversed during reprogramming, as confirmed by transcriptomic aging clocks. The longevity and rejuvenation effects induced by reprogramming in the transcriptome were mainly independent of pluripotency gain. Decoupling of these processes allowed predicting interventions mimicking reprogramming-induced rejuvenation (RIR) without affecting somatic cell identity, including an anti-inflammatory compound osthol, ATG5 overexpression, and C6ORF223 knockout. Overall, we revealed specific molecular mechanisms associated with RIR at the gene expression level and developed tools for discovering interventions that support the rejuvenation effect of reprogramming without posing the risk of neoplasia.

6 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDmitrii Kriukov
Dmitrii Kriukov
EEEvgeniy Efimov
Evgeniy Efimov
EKEkaterina Kuzmina
Ekaterina Kuzmina
ADAnastasiia Dudkovskaia
Anastasiia Dudkovskaia
EKEkaterina Khrameeva
Ekaterina Khrameeva
DDDmitry V. Dylov
Dmitry V. Dylov
The success of clinical trials of longevity drugs relies heavily on identifying integrative health and aging biomarkers, such as biological age. Epigenetic aging clocks predict the biological age of an individual using their DNA methylation profiles, commonly retrieved from blood samples. However, there is no standardized methodology to validate and compare epigenetic clock models as yet. We propose ComputAgeBench , a unifying framework that comprises such a methodology and a dataset for comprehensive benchmarking of different clinically relevant aging clocks. Our methodology exploits the core idea that reliable aging clocks must be able to distinguish between healthy individuals and those with aging-accelerating conditions. Specifically, we collected and harmonized 66 public datasets of blood DNA methylation, covering 19 such conditions across different ages, and tested 13 published clock models. Additionally, we compiled 46 separate datasets to facilitate the training of new aging clocks. We believe our work will bring the fields of aging biology and machine learning closer together for the research on reliable biomarkers of health and aging. Code: https://github.com/ComputationalAgingLab/ComputAge Dataset: https://huggingface.co/datasets/computage/computage_bench

3 August 2025
Verified
Conference Paper
Open access
DKDmitrii Kriukov
Dmitrii Kriukov
EEEvgeniy Efimov
Evgeniy Efimov
EKEkaterina Kuzmina
Ekaterina Kuzmina
ADAnastasiia Dudkovskaia
Anastasiia Dudkovskaia
EKEkaterina Khrameeva
Ekaterina Khrameeva
DDDmitry V. Dylov
Dmitry V. Dylov

7 November 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
AZAdam Zaretsky
Adam Zaretsky
AVAlfredo Garcia Venzor
Alfredo Garcia Venzor
EEEkaterina Eremenko
Ekaterina Eremenko
DSDaniel Stein
Daniel Stein
DSDmitrii Smirnov
Dmitrii Smirnov
DTDebra Toiber
Debra Toiber
RE-1 silencing transcription factor (REST) is a key repressor of neural genes. REST is upregulated under stress signals, aging and neurodegenerative diseases, but although it is upregulated, its function is lost in Alzheimer’s Disease. However, why it becomes inactive remains unclear. Here, we show that the NAD-dependent deacetylase SIRT6 regulates REST expression, location and activity. In the absence of SIRT6, REST is overexpressed but mislocalized, leading to a partial loss of its activity and causing it to become toxic. SIRT6 deficiency abrogates REST and EZH2 interaction, perturbs the location of REST to the heterochromatin Lamin B ring, and leads to REST target gene overexpression. SIRT6 reintroduction or REST methyl-mimic K494M expression rescues this phenotype, while an acetyl-mimic mutant loses its function even in WT cells. Our studies define a novel regulatory switch where, depending on SIRT6 presence, the function of REST is regulated by post-translational modifications on K494 (Ac/me), affecting neuronal gene expression.